Abbott Laboratories (NYSE:ABT) reported on Friday that its board of directors authorised a common stock dividend of USD0.45 per share for the quarter, the company .
This 389th consecutive quarterly dividend will be paid on 17 May 2021 to shareholders of record at the close of business on 15 April 2021.
Also, the company said it has paid dividends since 1924 and increased its dividend payout for 49 consecutive years.
Abbott discovers, develops, manufactures and sells health care products worldwide. It operates through the Established Pharmaceutical Products segment; Diagnostic Products segment; and Medical Devices segment. It has an agreement with Tandem Diabetes Care to develop and commercialise integrated diabetes solutions.
The company was founded in 1888 and is headquartered in North Chicago, Illinois, USA.
TELA Bio launches LIQUIFIX for US hernia surgery
Cognizant and NVIDIA partner to revolutionize drug discovery with generative AI
Neupulse raises funds for Tourettes Syndrome wearable tech
Bonesupport gains FDA clearance for CERAMENT G in open fractures
Epitomee submits Weight Loss Capsule for FDA approval in US
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon